The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
The promise of minocycline in neurology
Abstract
The capacity of minocycline to alleviate disease for several neurological disorders in animals is increasingly being recognised. Indeed, that one drug alone can attenuate the severity of disease in stroke, multiple sclerosis, spinal-cord injury, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis is astounding. In this review, we describe the evidence for the efficacy of minocycline in several animal models of neurological disease, discuss the mechanisms by which minocycline affects a range of neurological diseases with diverse causes, and introduce the emerging investigation of minocycline in clinical neurology. The encouraging results of minocycline in experimental neurology bode well for its therapeutic use in human neurological diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thanks to the ability to efficiently cross the BBB, minocycline is considered neuroprotective for a variety of neurological conditions, including PD [251,252,253,254,255,256,257].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [253]
In the citing paper
“Thanks to the ability to efficiently cross the BBB, minocycline is considered neuroprotective for a variety of neurological conditions, including PD [251,252,253,254,255,256,257].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [253]
Citations
Cites
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Metalloproteinases in biology and pathology of the nervous system
Yong, W. V., Power, C., Forsyth, P., & Edwards, D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,094
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,069
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,060
Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Chen, D., Endres, R. L., Erickson, C. A., Weis, K. F., McGregor, M. W., Kawaoka, Y., & Payne, L. G. (2000) · Nature Medicine · doi:10.1038/80538 · Cited by 547
Research works printed but not linked: 1
- Giuliani, 2004, Synergistic activity of minocycline and glatiramer acetate in an animal model of multiple sclerosis, Mult Scler, 9, S76
Cited by
Sorted by citations
Minocycline: Far beyond an Antibiotic
Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935
Vandooren, J., den Steen, P. E. V., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 790
Activated Microglia Contribute to the Maintenance of Chronic Pain after Spinal Cord Injury
Hains, B. C., & Waxman, S. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0003-06.2006 · Cited by 641
Preclinical and clinical research on inflammation after intracerebral hemorrhage
Wang, J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.08.001 · Cited by 609
Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
Wong, M.-L., Inserra, A., Lewis, M. D., Mastronardi, C. A., Leong, L., Choo, J., Kentish, S., Xie, P., Morrison, M., Wesselingh, S. L., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.46 · Cited by 568
Metalloproteinases: Mediators of Pathology and Regeneration in the CNS
Yong, V. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1807 · Cited by 582
Minocycline and Neurodegenerative Diseases
Kim, H.-S., & Suh, Y.-H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.040 · Cited by 447
Hinwood, M., Morandini, J., Day, T. A., & Walker, F. R. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr229 · Cited by 420
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury
Casha, S., Zygun, D., McGowan, M.-B., Bains, I., Yong, V. W., & Hurlbert, R. J. (2012) · Brain · doi:10.1093/brain/aws072 · Cited by 407
Matrix metalloproteinases in brain development and remodeling: Synaptic functions and targets
Ethell, I. M., & Ethell, D. W. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21273 · Cited by 378
Liu, J., & Wang, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01005 · Cited by 376
Features of Microglia and Neuroinflammation Relevant to Environmental Exposure and Neurotoxicity
Kraft, A. D., & Harry, G. J. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8072980 · Cited by 340
Neuroinflammation in intracerebral haemorrhage: immunotherapies with potential for translation
Xue, M., & Yong, V. W. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30364-1 · Cited by 327
Lee, S. M., Yune, T. Y., Kim, S. J., Park, D. W., Lee, Y. K., Kim, Y. C., Oh, Y. J., Markelonis, G. J., & Oh, T. H. (2003) · Journal of Neurotrauma · doi:10.1089/089771503770195867 · Cited by 305
Schulz, R. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105230 · Cited by 293
Choi, Y., Kim, H., Shin, K. Y., Kim, E., Kim, M., Kim, H.-S., Park, C. H., Jeong, Y. H., Yoo, J., Lee, J., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301377 · Cited by 296
Can the immune system be harnessed to repair the CNS?
Popovich, P. G., & Longbrake, E. E. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2398 · Cited by 289
Minocycline as a Neuroprotective Agent
Stirling, D. P., Koochesfahani, K. M., Steeves, J. D., & Tetzlaff, W. (2005) · The Neuroscientist · doi:10.1177/1073858405275175 · Cited by 280
Recent advances in MMP inhibitor design
Fisher, J. F., & Mobashery, S. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7894-9 · Cited by 215
Peng, B., Xiao, J., Wang, K., So, K., Tipoe, G. L., & Lin, B. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5200-13.2014 · Cited by 259
Hawryluk, G. W. J., Rowland, J. W., Kwon, B. K., & Fehlings, M. G. (2008) · Neurosurgical FOCUS · doi:10.3171/foc.2008.25.11.e14 · Cited by 252
Hua, X., Svensson, C. I., Matsui, T., Fitzsimmons, B., Yaksh, T. L., & Webb, M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04451.x · Cited by 248
Dı́az-Hernández, M., Diez-Zaera, M., Sánchez‐Nogueiro, J., Gómez‐Villafuertes, R., Canals, J. M., Alberch, J., Miras‐Portugal, M. T., & Lucas, J. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-122275 · Cited by 228
Microglia Kv1.3 Channels Contribute to Their Ability to Kill Neurons
Fordyce, C. B., Jagasia, R., Zhu, X., & Schlichter, L. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1251-05.2005 · Cited by 213
Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205
Boyette-Davis, J. A., Xin, W., Zhang, H., & Dougherty, P. M. (2010) · Pain · doi:10.1016/j.pain.2010.10.030 · Cited by 202
Ulbrich, W., & Lamprecht, A. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0285.focus · Cited by 201
Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
Kühle, J., Gaiottino, J., Leppert, D., Petzold, A., Bestwick, J., Malaspina, A., Lu, C., Dobson, R., Disanto, G., Norgren, N., et al. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307454 · Cited by 197
Suter, M. R., Wen, Y., Décosterd, I., & Ji, R. (2007) · Neuron Glia Biology · doi:10.1017/s1740925x08000100 · Cited by 196
Communicating systems in the body: how microbiota and microglia cooperate
Erny, D., de Angelis, A. L. H., & Prinz, M. (2016) · Immunology · doi:10.1111/imm.12645 · Cited by 195
Microglia and macrophage phenotypes in intracerebral haemorrhage injury: therapeutic opportunities
Bai, Q., Xue, M., & Yong, V. W. (2019) · Brain · doi:10.1093/brain/awz393 · Cited by 191
Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury
Kabu, S., Gao, Y., Kwon, B. K., & Labhasetwar, V. D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.060 · Cited by 192
Mika, J., Osikowicz, M., Rojewska, E., Korostyński, M., Wawrzczak‐Bargieła, A., Przewłocki, R., & Przewłocka, B. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.030 · Cited by 187
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics
Camara-Lemarroy, C. R., Metz, L. M., Meddings, J. B., Sharkey, K. A., & Yong, V. W. (2018) · Brain · doi:10.1093/brain/awy131 · Cited by 188
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
Metz, L. M., Li, D. K. B., Traboulsee, A. L., Duquette, P., Eliasziw, M., Cerchiaro, G., Greenfield, J., Riddehough, A., Yeung, M., Kremenchutzky, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608889 · Cited by 186
Salaudeen, M. A., Bello, N., Danraka, R. N., & Ammani, M. L. (2024) · Biomolecules · doi:10.3390/biom14030305 · Cited by 223
Kwon, M. J., Kim, J., Shin, H., Jeong, S. R., Kang, Y. M., Choi, J. Y., Hwang, D. H., & Kim, B. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0278-13.2013 · Cited by 177
Recent Advances in Methamphetamine Neurotoxicity Mechanisms and Its Molecular Pathophysiology
Yu, S., Zhu, L., Shen, Q., Bai, X., & Di, X. (2015) · Behavioural Neurology · doi:10.1155/2015/103969 · Cited by 176
Inflammation in Neurological Disorders: A Help or a Hindrance?
Yong, V. W. (2010) · The Neuroscientist · doi:10.1177/1073858410371379 · Cited by 179
Matrix metalloprotease regulation of neuropathic pain
Ji, R., Xu, Z., Wang, X., & Lo, E. H. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.04.002 · Cited by 171
Zhou, H. Y., Lapointe, B. M., Clark, S., Zbytnuik, L. D., & Kubes, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8103 · Cited by 175
Siddiqui, A. M., Khazaei, M. R., & Fehlings, M. G. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2014.12.007 · Cited by 168
Zhang, H., Chang, M., Hansen, C. N., Basso, D. M., & Noble-Haeusslein, L. J. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0038-0 · Cited by 163
Genetics and Biomarkers of Moyamoya Disease: Significance ofRNF213as a Susceptibility Gene
Fujimura, M., Sonobe, S., Nishijima, Y., Niizuma, K., Sakata, H., Kure, S., & Tominaga, T. (2014) · Journal of Stroke · doi:10.5853/jos.2014.16.2.65 · Cited by 163
Selection of reference genes for quantitative real-time PCR in a rat asphyxial cardiac arrest model
Langnaese, K., John, R., Schweizer, H., Ebmeyer, U., & Keilhoff, G. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-53 · Cited by 160
Zhang, L., Kitaichi, K., Fujimoto, Y., Nakayama, H., Shimizu, E., Iyo, M., & Hashimoto, K. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.05.015 · Cited by 159
What is behind the non-antibiotic properties of minocycline?
Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.006 · Cited by 158
Pathogenesis of multiple sclerosis
Prat, A., & Antel, J. P. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169737.99040.31 · Cited by 160
Homsi, S., Piaggio, T., Croci, N., Noble, F., Plotkine, M., Marchand-Leroux, C., & Jafarian-Tehrani, M. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1223 · Cited by 158
Wasserman, J. K., & Schlichter, L. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.025 · Cited by 166
Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators
Yong, V. W., Zabad, R., Agrawal, S., DaSilva, A. G., & Metz, L. M. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.11.021 · Cited by 156
Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary
Lopez-Diego, R. S., & Weiner, H. L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2358 · Cited by 154
Intravenous Minocycline in Acute Stroke
Kohler, E., Prentice, D. A., Bates, T. R., Hankey, G. J., Claxton, A., van Heerden, J., & Blacker, D. (2013) · Stroke · doi:10.1161/strokeaha.113.000780 · Cited by 151
Homsi, S., Federico, F., Croci, N., Palmier, B., Plotkine, M., Marchand‐Leroux, C., & Jafarian-Tehrani, M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.031 · Cited by 147
Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
Miyaoka, T., Yasukawa, R., Yasuda, H., Hayashida, M., Inagaki, T., & Horiguchi, J. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181593d45 · Cited by 146
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
Matsukawa, N., Yasuhara, T., Hara, K., Xu, L., Maki, M., Yu, G., Kaneko, Y., Ojika, K., Hess, D. C., & Borlongan, C. V. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-126 · Cited by 146
Wang, N., Mi, X., Gao, B., Gu, J., Wang, W., Zhang, Y., & Wang, X. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.021 · Cited by 140
Wang, B., Huang, X., Pan, X., Zhang, T., Hou, C., Su, W., Liu, L.-L., Li, J., & Wang, Y. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.06.019 · Cited by 134
Rotschafer, S. E., Trujillo, M. S., Dansie, L. E., Ethell, I. M., & Razak, K. A. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.041 · Cited by 130
Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
Morris, G., Walker, A. J., Berk, M., Maes, M. H. J., & Puri, B. K. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0793-y · Cited by 134
Nagel, S., Su, Y., Horstmann, S., Heiland, S., Gardner, H., Koziol, J., Martinez-Torres, F. J., & Wagner, S. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.052 · Cited by 130
Fujimura, M., Niizuma, K., Inoue, T., Sato, K., Endo, H., Shimizu, H., & Tominaga, T. (2013) · Neurosurgery · doi:10.1227/neu.0000000000000238 · Cited by 128
Prow, N. A., & Irani, D. N. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05230.x · Cited by 126
The Gut-Microglia Connection: Implications for Central Nervous System Diseases
Wang, Y., Wang, Z., Wang, Y., Li, F., Jia, J., Song, X., Qin, S., Wang, R., Jin, F., Kitazato, K., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02325 · Cited by 130
The microglia in healthy and diseased retina
Li, L., Eter, N., & Heiduschka, P. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.04.020 · Cited by 112
Zabad, R. K., Metz, L. M., Todoruk, T. R., Zhang, Y., Mitchell, J. R., Yeung, M., Patry, D. G., Bell, R. B., & Yong, V. W. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070319 · Cited by 120
Systemic inflammation in traumatic spinal cord injury
Bloom, O., Herman, P. E., & Spungen, A. M. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113143 · Cited by 123
Matrix Metalloproteinases in Acute Intracerebral Hemorrhage
Lattanzi, S., Napoli, M. D., Ricci, S., & Divani, A. A. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00839-0 · Cited by 124
Doxycycline restrains glia and confers neuroprotection in a 6‐OHDA Parkinson model
Lazzarini, M., Martin, S., Mitkovski, M., Raisman‐Vozari, R., Stühmer, W., & Bel, E. D. (2013) · Glia · doi:10.1002/glia.22496 · Cited by 119
Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment
Goodall, G., & Morrison, K. E. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406010854 · Cited by 119
Microglial physiopathology: how to explain the dual role of microglia after acute neural disorders?
Gomes‐Leal, W. (2012) · Brain and Behavior · doi:10.1002/brb3.51 · Cited by 115
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
Stack, E. C., Smith, K. M., Ryu, H., Cormier, K., Chen, M., Hagerty, S. W., Del Signore, S. J., Cudkowicz, M. E., Friedlander, R. M., & Ferrante, R. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.11.002 · Cited by 114
Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic
Mancuso, R., & Navarro, X. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.004 · Cited by 125
Clinical Trials in Traumatic Spinal Cord Injury
Donovan, J. M., & Kirshblum, S. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0632-5 · Cited by 110
Asadi, A., Abdi, M., Kouhsari, E., Panahi, P., Sholeh, M., Sadeghifard, N., Amiriani, T., Ahmadi, A., Maleki, A., & Gholami, M. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.01.022 · Cited by 112
Microglia and inflammation: conspiracy, controversy or control?
Fernandes, A., Miller-Fleming, L., & Pais, T. F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1670-8 · Cited by 103
New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases
Scarian, E., Viola, C., Dragoni, F., Gerlando, R. D., Rizzo, B., Diamanti, L., Gagliardi, S., Bordoni, M., & Pansarasa, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052698 · Cited by 118
Doorduin, J., de Vries, E. F. J., Dierckx, R. A. J. O., & Klein, H. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549443 · Cited by 107
Current and future therapeutic strategies for functional repair of spinal cord injury
Tohda, C., & Kuboyama, T. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.006 · Cited by 107
Neuroprotection by Minocycline Caused by Direct and Specific Scavenging of Peroxynitrite
Schildknecht, S., Pape, R., Müller, N., Robotta, M., Marquardt, A., Bürkle, A., Drescher, M., & Leist, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169565 · Cited by 107
Theruvath, T. P., Zhong, Z., Pediaditakis, P., Ramshesh, V. K., Currin, R. T., Tikunov, A. P., Holmuhamedov, E., & Lemasters, J. J. (2007) · Hepatology · doi:10.1002/hep.21912 · Cited by 107
Zhang, L., Shirayama, Y., Iyo, M., & Hashimoto, K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301313 · Cited by 105
Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease
Bortolanza, M., Nascimento, G. C., Socías, S. B., Ploper, D., Chehín, R. N., Raisman‐Vozari, R., & Bel, E. A. D. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1913-1 · Cited by 104
Possible antipsychotic effects of minocycline in patients with schizophrenia
Miyaoka, T., Yasukawa, R., YASUDA, H., Hayashida, M., Inagaki, T., & Horiguchi, J. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.08.013 · Cited by 105
Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression
Marković, D., Vinnakota, K., van Rooijen, N., Kiwit, J., Synowitz, M., Glass, R., & Kettenmann, H. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.01.015 · Cited by 104
Evaluating therapeutic targets for reperfusion‐related brain hemorrhage
Maier, C. M., Hsieh, L. B., Crandall, T., Narasimhan, P., & Chan, P. H. (2006) · Annals of Neurology · doi:10.1002/ana.20850 · Cited by 103
Additive effect of the combination of glatiramer acetate and minocycline in a model of MS
Giuliani, F., Metz, L. M., Wilson, T., Fan, Y., Bar‐Or, A., & Yong, V. W. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.09.006 · Cited by 104
Anti-inflammatory treatments for stroke: from bench to bedside
Drieu, A., Levard, D., Vivien, D., & Rubio, M. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418789854 · Cited by 101
de Castro, M. M., Kandasamy, A. D., Youssef, N., & Schulz, R. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.05.005 · Cited by 102
Brain Autoimmunity and Intestinal Microbiota: 100 Trillion Game Changers
Wekerle, H. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.03.008 · Cited by 104
Fujita, Y., Ishima, T., Kunitachi, S., Hagiwara, H., Zhang, L., Iyo, M., & Hashimoto, K. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.031 · Cited by 99
Characterization of the Early Neuroinflammation After Spinal Cord Injury in Mice
Rice, T. K., Larsen, J., Rivest, S., & Yong, V. W. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000248552.07338.7f · Cited by 98
Metz, L., Li, D. K. B., Traboulsee, A. L., Myles, M. L., Duquette, P., Godin, J., Constantin, M., & Yong, V. W. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509106779 · Cited by 98
Modulating Inflammatory Cell Responses to Spinal Cord Injury: All in Good Time
Bowes, A. L., & Yip, P. K. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2014.3429 · Cited by 101
Heo, K., Cho, Y., Cho, K., Kim, H., Kim, H., Shin, H. Y., Lee, B. I., & Kim, G. W. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.027 · Cited by 97
Freire, M. A. M., Morya, E., Faber, J., dos Santos, J. R., Guimarães, J. S., Lemos, N. A. M., Sameshima, K., Pereira, A., Ribeiro, S. T. G., & Nicolelis, M. A. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027554 · Cited by 100
Ravikumar, M., Sunil, S., Black, J., Barkauskas, D. S., Haung, A. Y., Miller, R. H., Selkirk, S. M., & Capadona, J. R. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.084 · Cited by 97
Wasserman, J. K., & Schlichter, L. C. (2006) · Brain Research · doi:10.1016/j.brainres.2006.12.035 · Cited by 97
The Therapeutic Role of Minocycline in Parkinson’s Disease
Cankaya, S., Cankaya, B., Kilic, U., Kilic, E., & Yulug, B. (2019) · Drugs in Context · doi:10.7573/dic.212553 · Cited by 93
A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model
Pinzón, A., Marcillo, A. E., Quintana, A., Stamler, S., Bunge, M. B., Bramlett, H. M., & Dietrich, W. D. (2008) · Brain Research · doi:10.1016/j.brainres.2008.09.047 · Cited by 95
Metadata
- Authors
- Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Yong, V Wee
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 3
- Issue
- 12
- Pages
- 744-751
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2063885093
- Cited by
- 518
- References
- 64
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 17 · 2023: 19 · 2022: 20 · 2021: 19 · 2020: 24 · 2019: 14 · 2018: 27 · 2017: 19 · 2016: 17 · 2015: 28 · 2014: 33 · 2013: 32 · 2012: 35
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Teva Pharmaceutical Industries
- Multiple Sclerosis Society of Canada
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- minocycline, neuroprotection, stroke, multiple sclerosis, spinal cord injury, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, animal models of neurological disease, clinical trials
- MeSH terms
- Animals, Humans, Minocycline, Nervous System Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review